
Chinese chemistry technology company established in January 2022 in Shanghai and incubated with investment from Megarobo, a leading Chinese life science intelligent manufacturing company. Aims to shorten the chemical synthesis stage of new drug development through closed loop collaboration between two technology platforms, artificial intelligence based chemical synthesis route planning and a high throughput fully automated laboratory, and raised twenty-six million US dollars in a Series A round co-led by Qiming Venture Partners and LYFE Capital to develop its products, open commercial markets and support international expansion.
View Company Profile
Leave your rating